PECAM1 and ischemic stroke: Compared with the control group, adjudin-treated mice displayed significantly greater numbers of NeuN+/BrdU+ and CD31+/BrdU+ cells at 35 days after tMCAO in the perifocal striatum region (Figures 6A–D), indicating that adjudin promoted neurogenesis and angiogenesis from ischemic stroke induced impairments.